Movers & Shakers

Premium

Vermillion this week named Sandra Gardiner as its chief financial officer.

Gardiner comes to Vermillion from Bend Research, where she had been CFO since March 2009. Previously she worked as CFO and corporate secretary of Lipid Sciences and held various positions at Cardima, Comac, and Advance Cardiovascular Systems.

She will be responsible for all aspects of financial management at Vermillion, which emerged from Chapter 11 bankruptcy protection in January of this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.